ID: ALA2259931

Max Phase: Preclinical

Molecular Formula: C16H26N2O

Molecular Weight: 262.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(CC(O)c1ccccc1)CC1CCCCN1C

Standard InChI:  InChI=1S/C16H26N2O/c1-17(12-15-10-6-7-11-18(15)2)13-16(19)14-8-4-3-5-9-14/h3-5,8-9,15-16,19H,6-7,10-13H2,1-2H3

Standard InChI Key:  BSUBMDLVQJXAJM-UHFFFAOYSA-N

Associated Targets(non-human)

Probable L-lysine-epsilon aminotransferase 60 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 262.40Molecular Weight (Monoisotopic): 262.2045AlogP: 2.14#Rotatable Bonds: 5
Polar Surface Area: 26.71Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.00CX LogP: 2.21CX LogD: 0.61
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.88Np Likeness Score: -0.65

References

1. Dube D, Tripathi SM, Ramachandran R.  (2008)  Identification of in vitro inhibitors of Mycobacterium tuberculosis Lysine -aminotransferase by pharmacophore mapping and three-dimensional flexible searches,  17  (2): [10.1007/s00044-007-9048-1]

Source